Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: A case report and review of the literature
Hormonal therapy for adjuvant treatment of ovarian cancer may provide a low toxicity option in some patients with refractory disease. A 53 year-old patient with stage IIIC papillary serous ovarian cancer previously treated with multiple chemotherapy regimens with platinum-resistant disease was treat...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2010-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2010/0354-73101002032K.pdf |